<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03933358</url>
  </required_header>
  <id_info>
    <org_study_id>BFH-Thyroid and STEMI</org_study_id>
    <nct_id>NCT03933358</nct_id>
  </id_info>
  <brief_title>Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients</brief_title>
  <acronym>ThyREST</acronym>
  <official_title>Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine whether thyroid hormone levels are predictive of cardiac
      remodeling following myocardial infarction and the prognosis in patients with STEMI receiving
      primary percutaneous coronary intervention.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MACE (major adverse cardiovascular events)</measure>
    <time_frame>12 months</time_frame>
    <description>cardiovascular death, re-infarction, revascularization, and stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse cardiac remodeling</measure>
    <time_frame>6 months</time_frame>
    <description>a cut-off value of 12% change in left ventricular end-diastolic volume between the acute and follow-up magnetic resonance scans</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>all-cause death</measure>
    <time_frame>12 months</time_frame>
    <description>death caused by all reason</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Thyroid</condition>
  <condition>Cardiac Remodeling, Ventricular</condition>
  <condition>STEMI</condition>
  <arm_group>
    <arm_group_label>Euthyroid</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Low T3</arm_group_label>
    <description>low triiodothyronine syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thyroid hormone levels</intervention_name>
    <description>This is an observational study. Exposure: Different thyroid hormone levels.</description>
    <arm_group_label>Euthyroid</arm_group_label>
    <arm_group_label>Low T3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Beijing Friendship Hospital with a confirmed STEMI diagnosis
        undergoing primary percutaneous coronary intervention
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  with a confirmed STEMI diagnosis

          -  undergoing primary percutaneous coronary intervention (presenting &lt;12h after symptom
             onset)

          -  patients agreed and provided informed consent

        Exclusion Criteria:

          -  past history of myocardial infarction or percutaneous coronary intervention or
             coronary artery bypass graft

          -  past history of heart failure (LVEF&lt;40%) or myocardiopathy or atrial fibrillation

          -  past history of thyroid diseases, or were treated with amiodarone, dopamine, or
             corticosteroids before hospital admission

          -  contraindicating to cardiac magnetic resonance imaging
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hongwei Li</last_name>
    <phone>0086 10 63139780</phone>
    <email>lhw19656@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Friendship Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen Su</last_name>
      <email>15901120705@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>April 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2019</study_first_posted>
  <last_update_submitted>May 1, 2019</last_update_submitted>
  <last_update_submitted_qc>May 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Hongwei Li, MD</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Ventricular Remodeling</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

